75 related articles for article (PubMed ID: 902682)
1. Genetic variation in antibody response and natural killer cell activity against a Moloney virus-induced lymphoma (YAC).
Asjö B; Kiessling R; Klein G; Povey S
Eur J Immunol; 1977 Aug; 7(8):554-8. PubMed ID: 902682
[TBL] [Abstract][Full Text] [Related]
2. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
3. Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response.
Debré P; Boyer B; Gisselbrecht S; Bismuth A; Lévy JP
Eur J Immunol; 1980 Dec; 10(12):914-8. PubMed ID: 6781910
[TBL] [Abstract][Full Text] [Related]
4. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens.
Vlug A; Melief CJ; de Bruyne C; Schoenmakers H; Molenaar JL
J Natl Cancer Inst; 1980 May; 64(5):1191-8. PubMed ID: 6245302
[TBL] [Abstract][Full Text] [Related]
7. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
[TBL] [Abstract][Full Text] [Related]
8. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
Grönberg A; Kiessling R; Eriksson E; Hansson M
J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
[No Abstract] [Full Text] [Related]
9. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
Chow DA; Wolosin LB; Greenberg AH
J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
[TBL] [Abstract][Full Text] [Related]
10. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma.
Becker S; Kiessling R; Lee N; Klein G
J Natl Cancer Inst; 1978 Dec; 61(6):1495-8. PubMed ID: 281556
[TBL] [Abstract][Full Text] [Related]
11. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of the natural killer cell activity in SJL and other strains of mice.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115
[TBL] [Abstract][Full Text] [Related]
13. Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigens.
Fenyo EM; Yefenof E; Klein E; Klein G
J Exp Med; 1977 Dec; 146(6):1521-33. PubMed ID: 925612
[TBL] [Abstract][Full Text] [Related]
14. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
15. Genes of the H-2 complex regulate the antibody response to murine leukemia virus.
Vlug A; Schoenmakers HJ; Melief CJ
J Immunol; 1981 Jun; 126(6):2355-60. PubMed ID: 6262410
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
17. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2.
Ng AK; McIntire R; Holden HT; Herberman RB
J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439
[No Abstract] [Full Text] [Related]
18. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells.
Devens B; Naor D
J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839
[TBL] [Abstract][Full Text] [Related]
19. Separation of the Moloney leukemia virus-determined cell surface antigen (MCSA) from known virion proteins associated with the cell membrane.
Siegert W; Fenyö EM; Klein G
Int J Cancer; 1977 Jul; 20(1):75-82. PubMed ID: 71277
[TBL] [Abstract][Full Text] [Related]
20. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus.
Storch TG; Chused TM
J Immunol; 1984 Nov; 133(5):2797-800. PubMed ID: 6332861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
